Table:
begin	end	state
1	60	non-cytoplasmic
61	81	transmembrane
82	107	cytoplasmic
108	133	transmembrane
134	150	non-cytoplasmic
151	172	transmembrane
173	181	cytoplasmic
182	202	transmembrane
203	229	non-cytoplasmic
230	250	transmembrane
251	263	cytoplasmic
264	289	transmembrane
290	303	non-cytoplasmic
304	325	transmembrane
326	345	cytoplasmic
346	367	transmembrane
368	372	non-cytoplasmic
373	394	transmembrane
395	413	cytoplasmic
414	432	transmembrane
433	436	non-cytoplasmic
437	455	transmembrane
456	480	cytoplasmic

Input:
>Echvi_1617 FitnessBrowser__Cola:Echvi_1617
MSDKKNLVQKLESVNEYEREAIPQNKLKSWKSFVGTYAGEHTAGTEFVLGPLFVAHGASA
VDLVSGLLVGNILAVLSWAFFTGKAATKTRHTLYFQLEKIAGSRFTMIYNLVNAVAFCFL
AGAMITVAATAVGIPFDLAMPALDDTLPTSLGFVLTVFVVGAITTVIAMFGFNQVVKFAN
IAAPWMIMIFVAAAVAVLPRLGINSIGDFWPVAKETIWSGVPLEGKTKFTFWHIMFFAWF
CNMAMHIGMADMSILRYAKKWTAGFATSTGVFLGHYVAWIASGILYSLFLLESDGSLVFA
PGPIAYEAVGIAGAICVIIAGWTTANPTLYRAGLAIQSINPNWKTWKVTLFVGLITTIAA
CFPALMMQLLDFVALYGLVLMPLGAVIFIDIFLFPKMGMQSNFAALTHRNFNPAVGITWL
ITLIFCLGLNLFAGVEIFFLGLPGWFVAVLVYIASSKIVQKNTSIPHTAKPNAKSEVPAS

Or try the official Phobius web server, which has a different display

Reference: Advantages of combined transmembrane topology and signal peptide prediction - the Phobius web server